# Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor

> **NCT00004159** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 54 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00004159
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-02
- **Primary completion:** 2000-02
- **Final completion:** 2000-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2013-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004159, "Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*